Nutritional Supplements & Complementary/AlternativeMedicine by Prostate & Breast Cancer Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01823549
Recruitment Status :
Active, not recruiting
First Posted : April 4, 2013
Last Update Posted : May 24, 2018
Ohio State University Comprehensive Cancer Center
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Steven Clinton, Ohio State University Comprehensive Cancer Center
This study was a survey to determine the frequency of Complementary and AlternativeMedicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.
Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation. [ Time Frame: Up to 1 year ]
Quantitate the various types of CAM therapy utilized by men with prostate cancer and women with breast cancer who are currently undergoing radiation therapy at The James Cancer Hospital and Solove Research Institute. Nutrient supplements and alternativemedication use is the primary focus of the assessment.
Determine if patients change their patterns of CAM use prior to, during, or after radiation treatment. [ Time Frame: Up to 1 year ]
Assess quality of life using validated instruments during radiation therapy and determine if there is a correlation between CAM use and quality of life. [ Time Frame: Up to 1 year ]
Assess radiation therapy toxicity using standardized criteria from the Oncology Nursing Society and determine if there is a correlation between CAM use and measures of toxicity. [ Time Frame: Up to 1 year ]
To determine predictive factors for CAM and nutritional supplement use, such as age, race, income, education, marital status, or tobacco/alcohol use. [ Time Frame: Up to 1 year ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
21 Years to 70 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Men with clinically localized prostate cancer that have chosen external beam irradiation or brachytherapy or a combination for their treatment and women with localized breast cancer who are scheduled to begin external beam radiation therapy as a component of their primary or adjuvant therapy.
Men that have histologically proven carcinoma of the prostate and have chosen some form of radiation therapy as their primary therapy for prostate cancer.
Women who are undergoing external beam radiation therapy to the breast as primary or adjuvant therapy are eligible.
All participants must be able to read and write.
Subjects with dementia and mental retardation that complicates completing the questionnaires will not be enrolled.
Subjects with known metastatic disease will be excluded.